Ticker

Analyst Price Targets — HSCS

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
December 19, 2022 8:32 amMaxim Group$3.00$0.90Benzinga Maxim Group Maintains Buy on Heart Test Laboratories, Lowers Price Target to $3

Latest News for HSCS

Analyzing Rennova Health (OTCMKTS:RNVA) & HeartSciences (NASDAQ:HSCS)

Rennova Health (OTCMKTS:RNVA - Get Free Report) and HeartSciences (NASDAQ: HSCS - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends. Analyst Recommendations This is a breakdown of recent

Defense World • Apr 27, 2026
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting

Southlake, TX, April 14, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”) a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), would like to remind its shareholders to vote ahead of its upcoming Annual Meeting of Shareholders (the “Annual Meeting”)…

GlobeNewsWire • Apr 14, 2026
Comparing 10x Genomics (NASDAQ:TXG) and HeartSciences (NASDAQ:HSCS)

10x Genomics (NASDAQ: TXG - Get Free Report) and HeartSciences (NASDAQ: HSCS - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings and valuation. Institutional and Insider Ownership 84.7% of 10x Genomics shares

Defense World • Apr 10, 2026
Hinge Health (NYSE:HNGE) versus HeartSciences (NASDAQ:HSCS) Financial Analysis

HeartSciences (NASDAQ: HSCS - Get Free Report) and Hinge Health (NYSE: HNGE - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership. Valuation and Earnings This table compares HeartSciences and Hinge

Defense World • Mar 26, 2026
HeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category

Southlake, TX , March 25, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc.   (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), today announced that its MyoVista Insights™ platform has received Epic Toolbox designation for the ECG Management System…

GlobeNewsWire • Mar 25, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for HSCS.

No House trades found for HSCS.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top